A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · Phase III
SITE007 (JPN) · Dr. Dubois
consented 2023-03-29
AEs
4
Serious
0
Dropout signal
–
Adverse events
mild
assessed
Grade 1 Diarrhoea — outcome: RECOVERED/RESOLVED; onset 2023-12-18 (study day 245); relationship: not assessed
moderate
assessed
Grade 2 Peripheral neuropathy — outcome: RECOVERED/RESOLVED; onset 2024-10-13 (study day 545); relationship: N
moderate
assessed
Grade 2 Stomatitis — outcome: RECOVERED/RESOLVED; onset 2024-12-17 (study day 610); relationship: N
mild
assessed
Grade 1 Anaemia — outcome: RECOVERED/RESOLVED; onset 2025-01-01 (study day 625); relationship: not assessed
Data queries
No data queries.